PCM
IMGN

PenderFund Capital Management’s Immunogen Inc IMGN Stock Holding History

PenderFund Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,580
Closed -$1.08M – 144
2023
Q4 		$1.08M Buy
+27,580
New +$549K 0.35% 33

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PenderFund Capital Management's IMGN Position: Q1 2024 in Review

PenderFund Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 27,580 shares — an estimated $1.08M sold.

PenderFund Capital Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $1.08M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • PenderFund Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • PenderFund Capital Management sold 27,580 Immunogen Inc shares in Q1 2024, an estimated $1.08M.
  • PenderFund Capital Management first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • PenderFund Capital Management's Immunogen Inc position peaked at $1.08M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on PenderFund Capital Management's 13F filing for Q1 2024, filed 15 May 2024.